Wednesday, November 4, 2026Updated every morning at 5:30 AM ET
NanotechProgress

Jan 2005

1 dated step on the record this month, newest first.

  • MedicineApproval

    Abraxane

    The FDA approved Abraxane for breast cancer that has spread, the first of a new class of albumin-bound nanoparticle drugs.

    Approved or on sale